Bildkälla: Stockfoto

SyntheticMR: Growth story to continue in 2023 - SEB

Although growth in Q4/22 was slower than in previous quarters, we continue to believe SyntheticMR will enjoy strong growth in 2023 thanks to its recently intensified relationship with OEMs and investment in its own sales efforts. We expect 35% growth in 2023, but after Q4 and considering the guidance for 2023 we cut our sales estimates for 2023-24 by 11%. Our new DCF-based fair value range is SEK 27-35 (previously SEK 31-40).

Although growth in Q4/22 was slower than in previous quarters, we continue to believe SyntheticMR will enjoy strong growth in 2023 thanks to its recently intensified relationship with OEMs and investment in its own sales efforts. We expect 35% growth in 2023, but after Q4 and considering the guidance for 2023 we cut our sales estimates for 2023-24 by 11%. Our new DCF-based fair value range is SEK 27-35 (previously SEK 31-40).
Börsvärldens nyhetsbrev
ANNONSER